Cargando…

The role of gut microbiome in immune modulation in metastatic renal cell carcinoma

Treatment of metastatic renal cell carcinomas (mRCC) has drastically improved since the advent of immunotherapy with immune checkpoint inhibitors (ICIs), with a significant proportion of patients achieving durable responses. While this has revolutionized treatment and improved outcomes for mRCC pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deluce, Jasna, Maleki Vareki, Saman, Fernandes, Ricardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465582/ https://www.ncbi.nlm.nih.gov/pubmed/36105887 http://dx.doi.org/10.1177/17588359221122714

Ejemplares similares

Next Wave of Targets in the Treatment of Advanced Renal Cell Carcinoma
por: Cardenas, Luisa M., et al.
Publicado: (2022)

Emerging Biomarker-Guided Therapies in Prostate Cancer
por: Deluce, Jasna E., et al.
Publicado: (2022)

The role of gut microbiome in modulating response to immune checkpoint inhibitor therapy in cancer
por: Naqash, Abdul Rafeh, et al.
Publicado: (2021)

The Effect of the Gut Microbiota on Systemic and Anti-Tumor Immunity and Response to Systemic Therapy against Cancer
por: Aghamajidi, Azin, et al.
Publicado: (2022)

Improved MAIT cell functions following fecal microbiota transplantation for metastatic renal cell carcinoma
por: Ninkov, Marina, et al.
Publicado: (2022)

The Gut Microbiome and Metastatic Renal Cell Carcinoma
por: Meza, Luis, et al.
Publicado: (2023)

High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors
por: Maleki Vareki, Saman
Publicado: (2018)

BMI, irAE, and gene expression signatures associate with resistance to immune-checkpoint inhibition and outcomes in renal cell carcinoma
por: Labadie, Brian W., et al.
Publicado: (2019)

The Role of Microbiota-Derived Vitamins in Immune Homeostasis and Enhancing Cancer Immunotherapy
por: Gholami, Hasti, et al.
Publicado: (2023)

Moving on from Metchnikoff: thinking about microbiome therapeutics in cancer
por: Vareki, Saman Maleki, et al.
Publicado: (2018)

Addressing the Elephant in the Immunotherapy Room: Effector T-Cell Priming versus Depletion of Regulatory T-Cells by Anti-CTLA-4 Therapy
por: Hong, Megan M Y, et al.
Publicado: (2022)

Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Cancer and Immunotherapy
por: Krishnamoorthy, Mithunah, et al.
Publicado: (2021)

Neoadjuvant Immunotherapy for High-Risk, Resectable Malignancies: Scientific Rationale and Clinical Challenges
por: Krishnamoorthy, Mithunah, et al.
Publicado: (2021)

EVALUATING HUMAN MICROBIOME SIGNATURES ASSOCIATED WITH DEVELOPMENT, OUTCOME, AND TREATMENT RESPONSE IN GLIOMA AND BRAIN METASTASIS: A SCOPING REVIEW
por: Leigh, J, et al.
Publicado: (2023)

Suspected immune checkpoint inhibitor‐induced pulmonary sarcoid reaction in metastatic renal cell carcinoma
por: Purcell, Victoria, et al.
Publicado: (2022)

COTI-2, a novel small molecule that is active against multiple human cancer cell lines in vitro and in vivo
por: Salim, Kowthar Y., et al.
Publicado: (2016)

Novel anti-cancer drug COTI-2 synergizes with therapeutic agents and does not induce resistance or exhibit cross-resistance in human cancer cell lines
por: Maleki Vareki, Saman, et al.
Publicado: (2018)

Enhanced donor screening for faecal microbial transplantation during COVID-19
por: Parvathy, Seema Nair, et al.
Publicado: (2021)

Gut microbiome in modulating immune checkpoint inhibitors
por: Li, Xiang, et al.
Publicado: (2022)

Immunomodulation in Pancreatic Cancer
por: Krishnamoorthy, Mithunah, et al.
Publicado: (2020)

Indoleamine 2,3-dioxygenase mediates immune-independent human tumor cell resistance to olaparib, gamma radiation, and cisplatin
por: Vareki, Saman Maleki, et al.
Publicado: (2014)

Gut microbiome modulates efficacy of immune checkpoint inhibitors
por: Yi, Ming, et al.
Publicado: (2018)

Inhibition of BRCA2 and Thymidylate Synthase Creates Multidrug Sensitive Tumor Cells via the Induction of Combined “Complementary Lethality”
por: Rytelewski, Mateusz, et al.
Publicado: (2013)

Real-World Evidence of Systemic Therapy Sequencing on Overall Survival for Patients with Metastatic BRAF-Mutated Cutaneous Melanoma
por: Kartolo, Adi, et al.
Publicado: (2022)

Correction: COTI-2, a novel small molecule that is active against multiple human cancer cell lines in vitro and in vivo
por: Salim, Kowthar Y., et al.
Publicado: (2017)

Perspective on the Role of Gut Microbiome in the Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

Randomized trial assessing impact of probiotic supplementation on gut microbiome and clinical outcome from targeted therapy in metastatic renal cell carcinoma
por: Dizman, Nazli, et al.
Publicado: (2020)

Role of the Gut Microbiome in Modulating Arthritis Progression in Mice
por: Liu, Xiaofei, et al.
Publicado: (2016)

HPV-Positive and -Negative Cervical Cancers Are Immunologically Distinct
por: Evans, Andris M., et al.
Publicado: (2022)

Microbiome-based interventions to modulate gut ecology and the immune system
por: Hitch, Thomas C. A., et al.
Publicado: (2022)

The effects of bare metal versus drug-eluting stent implantation on circulating endothelial cells following percutaneous coronary intervention(*)
por: Jazi, Seyed Mohammad Hashemi, et al.
Publicado: (2011)

Modulation of the Gut Microbiome to Improve Clinical Outcomes in Hepatocellular Carcinoma
por: Shen, Sj, et al.
Publicado: (2022)

Melatonin and cocaine: role of mitochondria, immunity, and gut microbiome
por: Anderson, George
Publicado: (2020)

Modulation of the gut microbiome with nisin
por: O’Reilly, Catherine, et al.
Publicado: (2023)

Role of surgery in advanced/metastatic renal cell carcinoma
por: Bhat, Suresh
Publicado: (2010)

The Role of Targeted Therapy in Metastatic Renal Cell Carcinoma
por: Unnithan, Jaya, et al.
Publicado: (2007)

Modulation of the Gut Microbiome to Enhance Immunotherapy Response in Metastatic Melanoma Patients: A Clinical Review
por: Najmi, Maleka, et al.
Publicado: (2022)

Role of Microbiome in Modulating Immune Responses in Cancer
por: Bose, Mukulika, et al.
Publicado: (2019)

Treatment-naïve HPV+ head and neck cancers display a T-cell-inflamed phenotype distinct from their HPV- counterparts that has implications for immunotherapy
por: Gameiro, Steven F., et al.
Publicado: (2018)

The Role of the Gut Microbiome, Immunity, and Neuroinflammation in the Pathophysiology of Eating Disorders
por: Butler, Michael J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vp1u38loaagqne3h3oh1f6rvgf